Your session is about to expire
← Back to Search
BP REACH Intervention for High Blood Pressure (BP-REACH Trial)
N/A
Recruiting
Led By Alejandra Casillas, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients of LA General Medical Center, Rancho Los Amigos, Olive Medical Center or Harbor-UCLA Medical Center with ischemic stroke, hemorrhagic stroke, or myocardial infarction
Be older than 18 years old
Must not have
Age < 35 years
Only speaks a language other than English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a team-based program to help reduce blood pressure for heart attack and stroke survivors. Participants get follow up with a pharmacist, education, and monthly phone calls from a health coach.
Who is the study for?
This trial is for English or Spanish speakers over 35 years old with high blood pressure (SBP ≥ 130 mm Hg) who have had a stroke or heart attack and are patients at specific LA medical centers. It's not for those who can't consent due to conditions like dementia.
What is being tested?
The BP REACH Intervention, a team-based program involving pharmacists and health coaches, aims to lower blood pressure in people with past strokes or heart attacks. It will be compared to usual care over a period of 12 months.
What are the potential side effects?
Since the intervention involves lifestyle coaching and medication management rather than new drugs, side effects may be minimal but could include potential stress from lifestyle changes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had a stroke or heart attack and am a patient at one of the specified medical centers.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 35 years old.
Select...
I speak a language other than English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Systolic blood pressure (SBP) mmHG
Secondary study objectives
BMI (body mass index)
Diet
HgbA1c (hemoglobin A1C)
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants follow the intervention protocol, including receiving educational materials, a home blood pressure monitor, coaching calls from BP REACH coaches and medication management from a pharmacist.
Group II: Usual CareActive Control1 Intervention
Participants receive the usual care received by patients of the medical center
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
946 Previous Clinical Trials
1,603,619 Total Patients Enrolled
University of California, Los AngelesOTHER
1,569 Previous Clinical Trials
10,313,289 Total Patients Enrolled
University of California, IrvineOTHER
566 Previous Clinical Trials
1,932,048 Total Patients Enrolled
Alejandra Casillas, MDPrincipal InvestigatorUniversity of California, Los Angeles
Amytis Towfighi, MDPrincipal InvestigatorUniversity of Southern California
1 Previous Clinical Trials
487 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your systolic blood pressure is 130 or higher.Your blood pressure is lower than 130 mm Hg.I am under 35 years old.I speak a language other than English or Spanish.I speak English or Spanish.I had a stroke or heart attack and am a patient at one of the specified medical centers.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.